Fruquin (Fruquintinib) 5mg

Fruquin (Fruquintinib) 5mg

Fruquin 5mg contains Fruquintinib, a targeted anticancer medicine used to treat metastatic colorectal cancer after prior therapies. Fruquintinib works by inhibiting VEGFR receptors, blocking tumor blood vessel formation, and slowing cancer progression.

Field Details
Original Brand Elunate
Generic Brand Fruquin 5
Generic Name Fruquintinib 5mg
Pack Size 21 Capsules (Typical Cycle Pack)
Use / Indications Metastatic Colorectal Cancer (mCRC)
Manufacturer Everest Pharmaceuticals Ltd. (Produced in Bangladesh)
Status Prescription Only Medicine

Introduction to Elunate (Fruquintinib) 5mg 

Elunate (Fruquintinib) 5mg is a prescription medicine used in the treatment of metastatic colorectal cancer (mCRC) in patients who have previously received standard therapies. This medicine belongs to a class of targeted oncology drugs known as vascular endothelial growth factor receptor (VEGFR) inhibitors, which work by blocking tumor blood vessel formation.

Elunate (Fruquintinib) 5mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Targeted Cancer Therapies. It contains Fruquintinib, which works by inhibiting VEGFR signaling and preventing tumors from forming new blood vessels that support cancer growth.

In some markets, Fruquin 5mg is available as a generic brand containing the same active ingredient Fruquintinib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.

What Is Elunate (Fruquintinib)? 

Elunate is the original brand name for Fruquintinib, an oral targeted therapy used in the treatment of advanced colorectal cancer that has progressed after previous treatments.

Fruquintinib belongs to a class of medicines known as selective VEGFR tyrosine kinase inhibitors, which target pathways involved in tumor angiogenesis.

Generic versions such as Fruquin 5mg contain the same active compound and may be used depending on physician recommendation and regional availability.

Drug Class and Mechanism of Action 

Fruquintinib is classified as a targeted anti-angiogenic agent with antineoplastic properties.

How Fruquintinib Works 

It works in several ways:

  • Selectively inhibits VEGFR-1, VEGFR-2, and VEGFR-3 receptors
  • Blocks tumor angiogenesis (formation of new blood vessels)
  • Limits tumor growth by reducing oxygen and nutrient supply

Through these mechanisms, Fruquintinib helps slow the progression of metastatic colorectal cancer.

How Elunate Works in the Body 

Tumors rely on the formation of new blood vessels to grow and spread. Elunate works by blocking this angiogenesis process.

Key Actions of Fruquintinib 

  • Prevents development of new blood vessels in tumors
  • Restricts tumor nutrient supply
  • Slows cancer progression in advanced colorectal cancer

Some generic versions such as Fruquin deliver the same active compound, allowing similar targeted cancer treatment when prescribed appropriately.

Medical Uses of Elunate (Fruquintinib) 5mg 

Elunate 5mg is primarily prescribed for patients with metastatic colorectal cancer who have received prior treatments.

Elunate for Metastatic Colorectal Cancer 

For patients with metastatic colorectal cancer that has progressed after chemotherapy and targeted therapies, Fruquintinib may be recommended.

Potential Benefits 

  • Improves progression-free survival
  • Slows tumor growth and spread
  • Provides a treatment option for previously treated mCRC patients

Generic alternatives like Fruquin 5mg may also be used under medical supervision when Fruquintinib therapy is recommended.

Who Can Take Fruquin 5mg? 

Because Fruquintinib is a potent targeted oncology medicine, treatment should always be supervised by an experienced oncologist.

Eligibility Criteria 

Patients may be prescribed Elunate if they:

  • Are diagnosed with metastatic colorectal cancer
  • Have previously received standard chemotherapy or targeted therapy
  • Are medically suitable for targeted anticancer treatment

Certain generic options such as Fruquin may also be considered depending on availability and physician decision.

Who Should Avoid Elunate (Fruquintinib) 5mg 

Elunate should NOT be used by:

  • Pregnant or breastfeeding women
  • Individuals with hypersensitivity to Fruquintinib
  • Patients with severe uncontrolled hypertension or bleeding disorders unless monitored by a specialist

Elunate (Fruquintinib) 5mg Dosage and Administration 

Standard Dosage Guidelines 

Typical dosage recommendations include:

  • Elunate 5mg once daily
  • Taken for 21 days followed by a 7-day rest period in a 28-day cycle
  • Capsules should be swallowed whole with water
  • Can be taken with or without food

Dosage Adjustments 

Doctors may adjust the dose depending on:

  • Blood pressure levels
  • Liver function
  • Individual treatment response and tolerance

Side Effects of Elunate 5mg 

Like all cancer medicines, Elunate may cause side effects.

Common Side Effects 

  • High blood pressure
  • Fatigue
  • Diarrhea
  • Decreased appetite
  • Hand-foot skin reactions

Serious Side Effects 

Severe Hypertension: Significant increase in blood pressure
Bleeding Risk: Gastrointestinal or other bleeding events
Liver Function Changes: Elevated liver enzymes

Patients should report any unusual symptoms to their doctor immediately.

Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the capsules in their original packaging and out of reach of children.

Frequently Asked Questions (FAQs) 

1. What is Elunate (Fruquintinib) 5mg used for? 

Elunate is used to treat metastatic colorectal cancer in patients who have previously received standard treatments.

2. Is Fruquintinib chemotherapy? 

No. Fruquintinib is a targeted therapy that blocks VEGFR receptors and prevents tumor blood vessel formation.

3. How long can patients take Fruquintinib? 

Treatment continues as long as the patient benefits from therapy and side effects remain manageable under medical supervision.

4. Does Fruquintinib cure colorectal cancer? 

Fruquintinib is not a cure but helps slow cancer progression and improve survival outcomes in advanced cases.

5. Is Fruquin 5mg the same as Elunate? 

Fruquin 5mg contains Fruquintinib, the same active ingredient found in Elunate. Generic versions is available. for more info. contact on WhatsApp: https://wa.me/8801742433764

6. Do I need a prescription to buy Fruquin (Fruquintinib) 5mg? 

Yes. Fruquin 5mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.

Medical Disclaimer 

Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Elunate (Fruquintinib) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.

 

Let's Chat!